18 June 2020 - A government scheme to fuel the development of new antibiotics by offering to pay pharmaceutical companies upfront for their work will start this week.

The NHS is offering two contracts to pay pharmaceutical companies at the start of their work for access to innovative antibiotics, as a means of incentivising the development of new classes of these drugs to patients across the UK for the first time in almost 30 years.

Of key focus are antibiotics that can provide alternative treatment options for serious infections, such as bloodstream infections, sepsis and hospital-acquired pneumonia.

Read Pharma Times article